comparison of ventilation with iGel vs LMA supreme during general anaesthesia using fibreoptic laryngoscopy

Comparison of position of LMA Supremeâ?¢ and i-gelâ?¢ with fibreoptic laryngoscopy in patients undergoing general anaesthesia with supraglottic airway devices: A Randomised Control Trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/04/018714

Enrollment

140

Registered

2019-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: LMA supreme: LMA supreme, a supra glottic airway device will be used to administer general anaesthesia Control Intervention1: LMA Supreme: LMA Supreme is a supra glottic device, commonl

Eligibility

Inclusion criteria

Inclusion criteria: adult patients of either sex ASA physical status I and II, undergoing General Anaesthesia with Supra Glottic Airway Device for surgical Procedures

Exclusion criteria

Exclusion criteria: Patients who are ASA 3 or 4 PS Emergency surgery Patients with risk factors for aspiration of gastric contents Anticipated duration of surgery more than 02 hours Difficult Airway Predictors - Mouth opening Neck extension Gd II or more Thyromental Distance of less than 5 cm Mallampati Classification 3 or 4 Jaw protrusion Gd B or C [4]

Design outcomes

Primary

Measure	Time frame
laryngeal view and epiglottic downfolding using fibre optic laryngoscopyTimepoint: immidiately after insertion	—

Secondary

Measure	Time frame
interventions required to obtain optimal position of the SADs using FOL Timepoint: immidiately;success of insertion of the SADs at first attempt, number of attempts required and the overall success rateTimepoint: immidiately after insertion of Supraglottic airway device	—

Countries

India

Contacts

Public ContactNeetika Tripathi

Armed Forces Medical College

drkirans@gmail.com9823464596

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026